Expansion Financing Opportunity
For a select group of technology companies, a new expansion financing program is available.
The minimum investment size is €5 Mio.
Please, contact me for further information.
For a select group of technology companies, a new expansion financing program is available.
The minimum investment size is €5 Mio.
Please, contact me for further information.
€1 Bio Equity Fund for Investments in Europe
A renowned investment society announced the closure of a €1Bio investment fund dedicated to investments in profitable European technology companies.
The minimum investment size is €20 Mio.
Please, contact me for further information.
A renowned investment society announced the closure of a €1Bio investment fund dedicated to investments in profitable European technology companies.
The minimum investment size is €20 Mio.
Please, contact me for further information.
In-Focus Client Company
Based in Vienna, Austria, this company develops antiallergic and antiallergic drugs from marine organisms. Their first product on the market is a clinically proven antiviral nasal spray against the common cold virus
Based in Vienna, Austria, this company develops antiallergic and antiallergic drugs from marine organisms. Their first product on the market is a clinically proven antiviral nasal spray against the common cold virus
